Vodafone launches M-Pesa technology in India

Vodafone's Indian division on Wednesday announced that it, together with ICICI Bank, has launched its M-Pesa technology, a mobile money tranfer and payment service, in India, giving 700m people access to conventional banking.

Vodafone's Indian division on Wednesday announced that it, together with ICICI Bank, has launched its M-Pesa technology, a mobile money tranfer and payment service, in India, giving 700m people access to conventional banking.

M-Pesa, which has 17.3m active customers across eight countries, enables users to pay money into any bank account in India, transfer money, pay utility bills, and deposit / withdraw money from designated outlets through simple technology.

Marten Pieters, Managing Director and Chief Executive Officer of Vodafone India, said: "For millions of people in India, a mobile phone is a bank account, a front door to a micro-business or a lifeline to people in the remotest areas.

"Research shows that M-Pesa brings real benefits to users in their daily lives, saving three hours a week of their time and around three dollars in money transfer costs - a significant amount to people in some areas.

"In partnership with ICICI Bank, we will provide people in remote areas with a convenient way to bank, transfer money and make payments in a safe and secure manner. We have customised our offering to serve the needs of Indian customers while ensuring its compliance with all applicable regulations.

"Financial inclusion is a national priority and we believe that with M-Pesa, we now have the ideal offering to enable this."

Vodafone's share price had edged 0.03% lower to 189.85p by 12:45 Wednesday.

NR

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022